216 related articles for article (PubMed ID: 12878541)
1. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
Laganas V; Alder J; Silverman JA
Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
[No Abstract] [Full Text] [Related]
4. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.
Hanberger H; Nilsson LE; Maller R; Isaksson B
Antimicrob Agents Chemother; 1991 Sep; 35(9):1710-6. PubMed ID: 1659305
[TBL] [Abstract][Full Text] [Related]
5. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
[TBL] [Abstract][Full Text] [Related]
6. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
7. Lipoteichoic acid as a target for antimicrobial action.
Canepari P; Boaretti M
Microb Drug Resist; 1996; 2(1):85-9. PubMed ID: 9158727
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
[TBL] [Abstract][Full Text] [Related]
9. Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids.
Ledger EVK; Pader V; Edwards AM
Microbiology (Reading); 2017 Oct; 163(10):1502-1508. PubMed ID: 28942757
[TBL] [Abstract][Full Text] [Related]
10. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
Stratton CW; Weeks LS
Diagn Microbiol Infect Dis; 1990; 13(3):245-52. PubMed ID: 2166634
[TBL] [Abstract][Full Text] [Related]
11. Lipoteichoic Acid Biosynthesis Inhibitors as Potent Inhibitors of
Naclerio GA; Onyedibe KI; Sintim HO
Molecules; 2020 May; 25(10):. PubMed ID: 32408616
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
Blenkharn JI; Darrell JH
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):734-7. PubMed ID: 2550236
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial Small Molecules That Potently Inhibit Staphylococcus aureus Lipoteichoic Acid Biosynthesis.
Naclerio GA; Karanja CW; Opoku-Temeng C; Sintim HO
ChemMedChem; 2019 May; 14(10):1000-1004. PubMed ID: 30939229
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of vancomycin and daptomycin against clinical isolates of Staphylococcus aureus and enterococci from India.
Jain S; Gaind R; Chugh TD
Int J Antimicrob Agents; 2013 Jul; 42(1):94-5. PubMed ID: 23611307
[No Abstract] [Full Text] [Related]
15. In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Bush LM; Boscia JA; Wendeler M; Pitsakis PG; Kaye D
Antimicrob Agents Chemother; 1989 Aug; 33(8):1198-200. PubMed ID: 2552901
[TBL] [Abstract][Full Text] [Related]
16. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
[TBL] [Abstract][Full Text] [Related]
17. The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis.
Boaretti M; Canepari P; Lleò MM; Satta G
J Antimicrob Chemother; 1993 Feb; 31(2):227-35. PubMed ID: 8385093
[TBL] [Abstract][Full Text] [Related]
18. A current perspective on daptomycin for the clinical microbiologist.
Humphries RM; Pollett S; Sakoulas G
Clin Microbiol Rev; 2013 Oct; 26(4):759-80. PubMed ID: 24092854
[TBL] [Abstract][Full Text] [Related]
19. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
20. False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci.
Palavecino EL; Burnell JM
J Clin Microbiol; 2013 Jan; 51(1):281-3. PubMed ID: 23077121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
